These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6154613)

  • 1. Involvement of antithrombin III in anticoagulant effects of sulphated polysaccharides [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):82-3. PubMed ID: 6154613
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Apr; 68(4):645-9. PubMed ID: 7378640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):85-6. PubMed ID: 6154614
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
    Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
    Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of polyanions and polycations on the trehalose phosphate synthetase of Mycobacterium smegmatis.
    Elbein AD; Mitchell M
    Carbohydr Res; 1974 Oct; 37(1):223-8. PubMed ID: 4429969
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
    Carlson TH; Kolman MR; Piepkorn M
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of anticoagulant effects of some sulphated polysaccharides.
    Andersson LO; Hoffman J; Holmer E; Larm O; Larsson K; Söderström G
    Thromb Res; 1982 Dec; 28(6):741-7. PubMed ID: 6132465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
    Blaskó G
    Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.